您当前的位置:
首页 >
文章列表页 >
Chimeric Antigen Receptor T Cells Therapy for the Treatment of B-lymphoblastic Hematologic Malignancy :A Rapid Health Technology Assessment
更新时间:2022-06-21
    • Chimeric Antigen Receptor T Cells Therapy for the Treatment of B-lymphoblastic Hematologic Malignancy :A Rapid Health Technology Assessment

    • China Pharmacy   Vol. 32, Issue 23, (2021)
    • Published:2021

    扫 描 看 全 文

  • HU Zixin, XIE Jinping, WANG Wanru, et al. Chimeric Antigen Receptor T Cells Therapy for the Treatment of B-lymphoblastic Hematologic Malignancy :A Rapid Health Technology Assessment. [J]. China Pharmacy 32(23).(2021) DOI:

  •  
  •  

0

Views

3

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

A Rapid Health Technology Assessment of Rosuvastatin Applicated in Patients with Dyslipidemia

Related Author

LI Chao
JIANG Wenliang
YANG Zixian
LI Kexin
NI Qian
PEI Yifang
LI Ting
TAN Ling

Related Institution

No data
0